GE HealthCare today announced a $138 million investment to expand its Carrigtohill, Cork contrast media fill and finish manufacturing site in Ireland. A new state-of-the-art facility on the grounds of ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

A new EMA approval has expanded the use of Vertex Pharma’s cystic fibrosis therapy ... including Denmark and Ireland. "Today’s approval brings us closer to our ultimate goal of providing ...

NMI®, a global leader in embedded payments infrastructure, announces NMI Customer Token Vault, a new extension to the NMI Gateway. Customer Token Vault introduces network tokenization with dynamic ...

Jazz Pharmaceuticals has agreed another pipeline ... head of R&D at Dublin, Ireland-headquartered Jazz. “Redx has discovered a number of preclinical KRAS candidates and we plan to leverage ...

Vertex Pharmaceuticals ( VRTX) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs, and ...

NEW YORK, NY / ACCESS Newswire / February 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex ...

Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company known for its cystic fibrosis (CF) treatments, is at a critical juncture as it seeks to diversify its portfolio and maintain its ...

Vertex Pharmaceuticals (VRTX) stock has performed strongly since the turn of the year, gaining 14.6% and vastly outperforming the healthcare ...

JOSEPH PREZIOSO / AFP via Getty Images Vertex Pharmaceuticals' non-opioid painkiller received approval from the Food and Drug Administration. The drugmaker said the twice-daily pill, Journavx ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug Administration (FDA). The company’s "first-in-class" suzetrigine pain pill ...